The startup develops magnetic field equipment that utilizes a targeting system to guide stem cells for cartilage regeneration in patients with knee osteoarthritis. This technology enables precise delivery of magnetic stem cells to the affected joint area, effectively alleviating pain and improving joint function.
Funding
Funding not disclosed
Founders
Product
Problem
Osteoarthritis patients often suffer from cartilage degradation in the knee joint, leading to pain and impaired mobility. Current treatments have limitations in precisely targeting and delivering regenerative therapies to the affected area.
Solution
This startup is developing a magnetic field-based technology to enhance stem cell therapy for knee osteoarthritis. The system uses magnetic targeting to guide magnetically labeled stem cells to the damaged cartilage within the knee joint. By precisely delivering stem cells to the site of injury, the technology aims to promote cartilage regeneration, reduce pain, and improve joint function. The approach offers a minimally invasive method for targeted stem cell delivery, potentially improving the efficacy of cartilage repair.
Target Audience
The primary target audience includes osteoarthritis patients seeking advanced regenerative therapies, orthopedic surgeons, and clinical researchers in the field of cartilage repair.
Features
- Magnetic targeting system for precise delivery of stem cells to the knee joint
- Magnetically labeled mesenchymal stem cells for cartilage regeneration
- Minimally invasive delivery method
- Technology based on research from Hiroshima University, which received the Minister of Education, Culture, Sports, Science and Technology Award
- Support for manufacturing partnerships and clinical trials